Interpace Diagnostics said today that Independence Blue Cross has agreed to cover Interpace’s thyroid tests, ThyGeNext and ThyraMir, for patients with thyroid cancer.
Independence covers about 2.5 million individuals in Philadelphia and Southeastern Pennsylvania.
Source: https://www.genomeweb.com/cancer/interpace-diagnostics-thyroid-assays-covered-independence-blue-cross
